Paper3136117
Potentiation of antitumor activity of macrophages by recombinant interferon alpha A/D contained in gelatin microspheres.
Tabata Y and 3 others. Jpn J Cancer Res, 1988. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Potentiation of antitumor activity of macrophages by recombinant interferon alpha A/D contained in gelatin microspheres. Papers, record 3136117. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3136117
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Potentiation of antitumor activity of macrophages by recombinant interferon alpha A/D contained in gelatin microspheres.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferon Type I | Major topic |
| Macrophages | Major topic |
| Animals | |
| Female | |
| Gelatin | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C3H | |
| Microscopy, Electron | |
| Microspheres | |
| Phagocytosis | |
| Recombinant Proteins | |
| Species Specificity |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3921232 | Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon. | Cancer Immunol Immunother | 1985 | https://conductscience.org/library/papers/3921232 | PubMed |
| 2 | 2410097 | Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors. | Cancer Res | 1985 | https://conductscience.org/library/papers/2410097 | PubMed |
| 3 | 6158375 | Augmentation of human monocyte-mediated cytolysis by interferon. | Cell Immunol | 1980 | https://conductscience.org/library/papers/6158375 | PubMed |
| 4 | 7365733 | Tumor cytotoxicity of rat alveolar macrophages activated in vitro by endotoxin. | J Reticuloendothel Soc | 1980 | https://conductscience.org/library/papers/7365733 | PubMed |
| 5 | 204610 | Recognition and destruction of target cells by tumoricidal macrophages. | Isr J Med Sci | 1978 | https://conductscience.org/library/papers/204610 | PubMed |
| 6 | 80335 | Ontogeny of macrophage function. I. Phagocytic activity and A-cell activity of newborn and adult mouse peritoneal macrophages. | Dev Comp Immunol | 1978 | https://conductscience.org/library/papers/80335 | PubMed |
| 7 | 4473563 | Discrimination between neoplastic and non-neoplastic cells in vitro by activated macrophages. | J Natl Cancer Inst | 1974 | https://conductscience.org/library/papers/4473563 | PubMed |
| 8 | 568163 | Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells. | J Exp Med | 1978 | https://conductscience.org/library/papers/568163 | PubMed |
| 9 | 1180867 | Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids. | Biken J | 1975 | https://conductscience.org/library/papers/1180867 | PubMed |
| 10 | 3841037 | Antitumor and antimetastatic activities of human recombinant interferon alpha A/D. | Clin Exp Metastasis | 1985 | https://conductscience.org/library/papers/3841037 | PubMed |
| 11 | 2890735 | Macrophage activation through phagocytosis of muramyl dipeptide encapsulated in gelatin microspheres. | J Pharm Pharmacol | 1987 | https://conductscience.org/library/papers/2890735 | PubMed |
| 12 | 1092874 | Interaction of BCG-activated macrophages with neoplastic and nonneoplastic cell lines in vitro : quantitation of the cytotoxic reaction by release of tritiated thymidine from prelabeled target cells. | J Natl Cancer Inst | 1975 | https://conductscience.org/library/papers/1092874 | PubMed |
| 13 | 4606813 | Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. | Biochem Biophys Res Commun | 1974 | https://conductscience.org/library/papers/4606813 | PubMed |
| 14 | 7430249 | Fibronectin-mediated uptake of gelatin-coated latex particles by peritoneal macrophages. | J Cell Biol | 1980 | https://conductscience.org/library/papers/7430249 | PubMed |
| 15 | 4813256 | Microencapsulation of a waxy solid: wall thickness and surface appearance studies. | J Pharm Sci | 1974 | https://conductscience.org/library/papers/4813256 | PubMed |
| 16 | 4553694 | Mechanism of immunologically specific killing of tumour cells by macrophages. | Nature | 1972 | https://conductscience.org/library/papers/4553694 | PubMed |
| 17 | 5383986 | Intravascular retention, dispersal, excretion and break-down of gelatin plasma substitutes. | Bibl Haematol | 1969 | https://conductscience.org/library/papers/5383986 | PubMed |
| 18 | 3871818 | Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. | J Immunol | 1985 | https://conductscience.org/library/papers/3871818 | PubMed |
| 19 | 3923117 | Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages. | J Immunol | 1985 | https://conductscience.org/library/papers/3923117 | PubMed |
| 20 | 6480158 | Inhibition of experimentally-induced murine metastases by recombinant alpha interferon: correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases. | Int J Cancer | 1984 | https://conductscience.org/library/papers/6480158 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22194039 | Clinical trial of cisplatin-conjugated gelatin microspheres for patients with hepatocellular carcinoma. | Jpn J Radiol | 2012 | https://conductscience.org/library/papers/22194039 | PubMed |
| 17923785 | Degradable gelatin microspheres as an embolic agent: an experimental study in a rabbit renal model. | Korean J Radiol | 2007 | https://conductscience.org/library/papers/17923785 | PubMed |
| 2501256 | In vivo effects of recombinant interferon alpha A/D incorporated in gelatin microspheres on murine tumor cell growth. | Jpn J Cancer Res | 1989 | https://conductscience.org/library/papers/2501256 | PubMed |
| 2473465 | Synthesis of gelatin microspheres containing interferon. | Pharm Res | 1989 | https://conductscience.org/library/papers/2473465 | PubMed |
| 1996352 | Mononuclear phagocytes: a major population of effector cells responsible for rejection of allografted tumor cells in mice. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1996352 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IFNA2 | 3440 | PubTator's text mining | https://conductscience.org/library/genes/3440 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3136117
GET https://conductscience.org/api/papers/v1/3136117/references?page=2